CAAMTECH
CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of modern medicine. CaaMTech is improving the health and happiness of humankind by creating and optimizing psychedelic compounds and formulations through rigorous science and continuous innovation.
CAAMTECH
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Issaquah, Washington, United States
Country:
United States
Website Url:
http://www.caam.tech
Total Employee:
1+
Status:
Active
Total Funding:
22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Sitelinks Search Box
Similar Organizations
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
Noetic Fund
Noetic Fund investment in Series A - CaaMTech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-17 | Bob Discordia Joins CaaMTech as Chief Scientific Officer |
Official Site Inspections
http://www.caam.tech Semrush global rank: 5.64 M Semrush visits lastest month: 1.5 K
Unable to get host informations!!!
More informations about "CaaMTech"
CaaMTech - Crunchbase Company Profile & Funding
Caam.tech/ 26,749; Highlights. obfuscated. Total Funding Amount . Unlock for free . Contacts 4. Employee Profiles 2. Investors 1. Similar Companies 5. ... 9,881 Number of Organizations • …See details»
CaaMTech | Pioneering Next-generation Psychedelic …
Pioneering next-generation serotonergic drugs. CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small-molecule therapeutics.See details»
About CaaMTech | Leading Psychedelic Drug Development
CaaMTech Company Profile 2024: Valuation, Funding …
CaaMTech General Information Description. Developer of medicine discovery and optimization technology designed to focus on engineering psychedelic drugs. The company creates and optimizes psychedelic compounds and formulations …See details»
Our Team - CaaMTech
Chief Technology Officer & Chief Marketing Officer. Davis Wuolle leads CaaMTech’s technology and marketing functions. His expertise lies in finding technological solutions to a diverse range of problems, from complex scientific …See details»
CaaMTech - LinkedIn
CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small-molecule therapeutics.See details»
CaaMTech Company Profile | Management and Employees List
Caam.tech . CaaMTech Profile and History. CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of …See details»
CaaMTech - Overview, News & Similar companies | ZoomInfo.com
Feb 16, 2022 CaaMTech contact info: Phone number: (206) 487-6917 Website: caam.tech What does CaaMTech do? CaaMTech is the foremost drug discovery and lead optimization …See details»
CaamTech Company Profile Funding & Investors | YourStory
CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small-molecule therapeutics.See details»
CaaMTech Company Profile - Office Locations, Competitors ... - Craft
CaaMTech has 5 employees at their 1 location and $22 m in total funding,. See insights on CaaMTech including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
CaaMTech - Neuly
Jan 1, 2019 Organizations CaaMTech CaaMTech. A privately held company CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to …See details»
CaaMTech Raises $22 Million for Psychedelic Drug Discovery
Aug 9, 2021 [email protected] +1.510.747.9001. Related Images. Image 1: CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development CaaMTech logo on green …See details»
CaaMTech Raises $22 Million for Psychedelic Drug Discovery and …
The investment provides CaaMTech with capital to advance compounds from its library into clinical trials CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development …See details»
CaaMTech LLC - Drug pipelines, Patents, Clinical trials - Synapse
The solid-state structure of N-methyl-serotonin {systematic name: [2-(5-hy-droxy-1H-indol-3-yl)eth-yl](meth-yl)aza-nium hydrogen oxalate}, C 11 H 15 N 2 O + ·C 2 HO 4-, is reported.The …See details»
CaaMTech Raises $22 Million for Psychedelic Drug Discovery and …
September 8, 2021. CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development. CaaMTech, Inc., a leading psychedelic drug discovery company, has today …See details»
CaaMTech’s Psychedelic Functional Unblinding Strategy Gets …
ISSAQUAH, Wash., November 14, 2024 (Newswire.com) - CaaMTech, Inc. is pleased to announce positive feedback from United States federal government regulators for its CT-4201 …See details»
CAAMTECH
CAAMTECH is a system integrator consulting firm specializing in managing technologies and supply chain networks, integrating them into a single, cohesive solution resulting in a …See details»
Updates - CaaMTech
Mar 28, 2023 August 4, 2023. CaaMTech and University of Massachusetts Dartmouth Collaborate to Research N-Cyclohexyltryptamine Structures. Dialkyl tryptamines have …See details»
CAAM Announces Support for INSAT’s Innovative Decarbonization …
Nov 7, 2024 Canadian Advanced Air Mobility (CAAM) is the federal not-for-profit organization representing the voice of the Advanced Air Mobility (AAM) industry in Canada. CAAM has …See details»
FDA Blesses CaaMTech’s Psychedelic Functional Unblinding Strategy
November 14, 2024. FDA Blesses CaaMTech’s Psychedelic Functional Unblinding Strategy. CaaMTech’s new clinical trial design solves the emergent functional unblinding problems …See details»